STOCK TITAN
  1. Home
  2. MCADU

BETTER THERAPEUTICS Stock Price, News & Analysis

MCADU NASDAQ

Company Description

BETTER THERAPEUTICS (NASDAQ: MCADU) is a publicly traded company.

MCADU stock has gained 11.0% over the past year.

This page provides a comprehensive overview of MCADU stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
+10.96%
Performance 1 year
$0.0
Market Cap
5.9M
Shares outstanding

BETTER THERAPEUTICS (MCADU) stock. Over the past 12 months, the stock has gained 11.0%.

Latest News

View All
+0.85%

Better Therapeutics to Participate in Lake Street’s 5th Annual Best Ideas Growth (BIG5) Conference on September 14-15, 2021

conferences
-0.06%

Better Therapeutics Highlights Recent Progress and Updates Outlook Through 2022

-0.79%

Better Therapeutics Secures $50 Million Debt Facility From Hercules Capital

+1.52%

Better Therapeutics Expands Real-World Evidence Study Initiative With Addition of Catalyst Health Network

-0.10%

Mountain Crest Acquisition Corp. II Announces that Common Stock and Rights to Commence Separate Trading on or about March 17, 2021

acquisition
-0.67%

Mountain Crest Acquisition Corp. II Announces Closing of Fully-Exercised Over-Allotment Option in Connection with Its Initial Public Offering

IPO offering acquisition

BETTER THERAPEUTICS has 8 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 5 with negative movement. Key topics include conferences, acquisition, IPO, offering. View all MCADU news →

SEC Filings

View All

No SEC filings available for MCADU.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months